Submission Details
| 510(k) Number | K193532 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 20, 2019 |
| Decision Date | March 02, 2020 |
| Days to Decision | 73 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K193532 is an FDA 510(k) clearance for the LIAISON Anti-HAV Assay, a Hepatitis A Test (antibody And Igm Antibody) (Class II — Special Controls, product code LOL), submitted by DiaSorin, Inc. (Stillwater, US). The FDA issued a Cleared decision on March 2, 2020, 73 days after receiving the submission on December 20, 2019. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3310.
| 510(k) Number | K193532 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 20, 2019 |
| Decision Date | March 02, 2020 |
| Days to Decision | 73 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LOL — Hepatitis A Test (antibody And Igm Antibody) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3310 |